Formulation and Characterization of Liquisolid Tablet of Skeletal Muscle Relaxants and Anti-Inflammatory Drugs

Authors

  • Amit B. Patil Department of Pharmaceutical Sciences, NGSM Institute of Pharmaceutical Sciences, Nitte University, Mangalore, India
  • Nandini Bangera Nitte University, Department of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences. Paneer, Deralakatte, Mangalore, Karnataka, India

DOI:

https://doi.org/10.37591/rrjodfdp.v2i2.325

Abstract

Baclofen is a skeletal muscle relaxants and nimesulide is a Non- steroidal anti- inflammatory drug (NSAID). Baclofen is used in the treatment of muscle spasm, arthritis and spondylitis. NSAID’s are preferred to reduce the symptoms caused by muscle spasm i.e., severe pain and fever. Hence combination of drug is used to minimise the frequent use of the drug. The main objective of the present work was to enhance solubility and dissolution rate by formulating and developing liquisolid system. To reduce the frequency of administration and patient compliance, liquisolid tablets were prepared by developing the mathematical model with different carrier and coating material and non-volatile solvents viz. Avicel PH 102, Aerosil, PEG 400 and PG. After fixing the concentration of drug and solvent, the drug release were carried for desired time. Combination of baclofen and nimesulide in the form of conventional tablet were prepared and drug release study was compared with liquisolid tablet. The drug release rate for liquisolid tablet was 98.52±0.062% for baclofen and 69±0.4% for nimesulide in 60 min and for conventional tablet 50.68% for baclofen and 39.68% for nimesulide in 60 min. The prepared tablets were evaluated for other parameters like general appearance, drug content uniformity, hardness, friability and in vitro disintegration studies. The best fit model for all the formulations was Hixson- Crowell model and release of drug mechanism was found to be non- Fickian. All the twelve formulations were subjected to stability studies at room temperature (25±2˚C) for a period of 8 weeks and found that there was no change in drug content.

 

Keywords: Liquisolid tablet, baclofen, nimesulide

Downloads

Published

2019-02-26

Issue

Vol. 2 No. 2 (2015)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.